NCT01740934

A Study to Evaluate the Safety, Tolerability, and Effects of Anatabloc® Crème in Rosacea

An Eight-Week, Multi-Site, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Trial to Evaluate the Safety, Tolerability, and Effects of Anatabloc® Crème in Subjects With Rosacea Followed by an Open-Label Extension

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 117 (actual)
• Sponsor: Rock Creek Pharmaceuticals, Inc. · Industry
• Sex: All
• Age: 25 Years – 70 Years
• Healthy volunteers: Accepted

Summary

This is a multi-site, four-visit, eight-week, double-blind, randomized, vehicle-controlled, parallel-group study followed by an eight-week open-label extension to evaluate the safety, tolerability, and potential effects of Anatabloc Facial Cream. The secondary aim is to evaluate if Anatabloc Facial Cream improves the appearance of the skin in subjects with mild to moderate rosacea.

Conditions

• Rosacea

Interventions

Type	Name	Description
OTHER	Anatabloc Cream	subject will apply active cream topically, twice per day according to instructions
OTHER	Placebo Cream	subject will apply placebo cream topically, twice per day according to instructions

Timeline

• Start date: 2012-11-01
• Primary completion: 2013-08-01
• Completion: 2013-08-01
• First posted: 2012-12-04
• Last updated: 2015-11-02

Locations

3 sites across 1 country: United States